Treatment of prostate cancer with a combination of abiraterone acetate and niraparib
US-2026097048-A1 · Apr 9, 2026 · US
Janssen Pharmaceutica Nv patents
Janssen Pharmaceutica Nv holds 1,523 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 1,523 |
| Recent patents | 296 |
| First publication | Jan 1, 2015 |
| Latest publication | Apr 9, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Novel synthetic options towards the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
US-2026092066-A1 · Apr 2, 2026 · US
Monoacylglycerol lipase modulators
US-12577243-B2 · Mar 17, 2026 · US
Synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators
US-12570658-B2 · Mar 10, 2026 · US
Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
US-2026060986-A1 · Mar 5, 2026 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Treatment of prostate cancer with a combination of abiraterone acetate and niraparib
US-2026097048-A1 · Apr 9, 2026 · US
Novel synthetic options towards the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
US-2026092066-A1 · Apr 2, 2026 · US
Monoacylglycerol lipase modulators
US-12577243-B2 · Mar 17, 2026 · US
Synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators
US-12570658-B2 · Mar 10, 2026 · US
Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
US-2026060986-A1 · Mar 5, 2026 · US
Top CPC classifications
Most common classification codes in this portfolio.
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1,378 |
| Chemistry & Metallurgy | 1,223 |
| Physics | 179 |
| Cross-Sectional Technologies | 64 |
| Operations & Transport | 44 |
| Electricity | 19 |
| Textiles & Paper | 2 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Janssen Pharmaceutica Nv have in patentsdb?
- Janssen Pharmaceutica Nv is linked to 1,523 publications as assignee in our database.
- What technology areas does Janssen Pharmaceutica Nv patent most?
- Top mapped technology areas by patent count: Human Necessities (1,378); Chemistry & Metallurgy (1,223); Physics (179).
- Is Janssen Pharmaceutica Nv's patent activity growing?
- In our data, assignee counts were 114 in 2024 and 84 in 2025 (lower year over year).
- What are recent patents assigned to Janssen Pharmaceutica Nv?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.